CrossingBridge Pre-Merger SPAC ETF
Limited financial coverage for SPC.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The CrossingBridge Pre-Merger SPAC ETF operates as an actively managed exchange-traded fund. Typically, it dedicates a minimum of 80% of its investable capital, including any funds acquired through borrowing, to equity and unit interests of Special Purpose Acquisition Companies (SPACs). The fund specifically targets SPACs that have not yet completed a shareholder-approved merger or business combination.
- IPO
- 2021
- HQ
- Wilmington, DE, US
Get TickerSpark's AI analysis on SPC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $18.39M
- Div Yield
- 13.75%
- 52W High
- $23.57
- 52W Low
- $16.85
- 50D MA
- $20.39
- 200D MA
- $21.22
- Beta
- 0.01
- RSI (14)
- 37
- Avg Volume
- 11.53K
No earnings-call transcripts are available for SPC yet.
- Free Float
- 0.0%
- Shares Outstanding
- 954.06K
- Float Shares
- 0
of shares held by institutions
13 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Lehman & Derafelo Financial Resources LLC | 11.10K | 0 |
| Mufg Americas Holdings Corp | 9.75K | ▲ 9.75K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 1, 08 | HEIL JOHN | other | 9,701 |
| Dec 1, 08 | HEIL JOHN | other | 11,709 |
| Nov 17, 08 | SHEPHERD THOMAS R | other | 8,000 |
| Nov 17, 08 | LUPO JOHN S | other | 8,000 |
| Nov 17, 08 | BOWLIN JOHN D | other | 10,000 |
| Oct 1, 08 | HEIL JOHN | other | 9,038 |
| Dec 6, 07 | HEIL JOHN | other | 6,127 |
| Oct 1, 07 | HEIL JOHN | other | 49,782 |
| Oct 1, 07 | Yoder Amy | other | 35,432 |
| Oct 1, 07 | BOWLIN JOHN D | other | 10,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SPC coverage
Recent articles, reports, and earnings notes.
No research on SPC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPC report →Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
globenewswire.com · Sep 18
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
globenewswire.com · Jun 29
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
globenewswire.com · Jun 23
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
globenewswire.com · Feb 18
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
globenewswire.com · Dec 30
SPC Financial Inc. Sells 970 Shares of NVIDIA Corporation $NVDA
defenseworld.net · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.